High throughput screening for compounds to the orphan nuclear receptor NR2F6-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High throughput screening for compounds to the orphan nuclear receptor NR2F6

Published:2022-06 Issue:4 Volume:27 Page:242-248
ISSN:2472-5552
Container-title:SLAS Discovery
language:en
Short-container-title:SLAS Discovery

Author:

Smith Emery,Campbell Sean,Wilson Adrianna N.,Shumate Justin,Baillargeon Pierre^ORCID,Scampavia Louis,Kamenecka Theodore M.,Spicer Timothy P.^ORCID,Solt Laura A.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference32 articles.

1. Adapting cancer immunotherapy models for the real world;Klevorn;Trends Immunol,2016

2. Elements of cancer immunity and the cancer-immune set point;Chen;Nature,2017

3. Mitigating the toxic effects of anticancer immunotherapy;Gangadhar;Nat Rev. Clin Oncol,2014

4. The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and Rev-erbs;Marciano;Cell Metabol,2014

5. Orphan nuclear receptors: shifting endocrinology into reverse;Kliewer;Science,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity;Science Advances;2023-07-07

2. In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients;Cancers;2023-06-12

3. Melanoma-intrinsic NR2F6 activity regulates anti-tumor immunity;2022-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP